Inventor
PIOTROWSKI DAVID W
US37 patents
⚠️ This page may combine multiple inventors who share the name “PIOTROWSKI DAVID W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
26 patentsUS10208019B2Feb 19, 2019
GLP-1 receptor agonists and uses thereof
PFIZER50 citations97
US7001900B2Feb 21, 2006
Azabicyclic compounds for the treatment of disease
PFIZER74 citations97
US6911543B2Jun 28, 2005
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
PFIZER71 citations96
US6919359B2Jul 19, 2005
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
PFIZER61 citations95
US11512070B2Nov 29, 2022
GLP-1 receptor agonists and uses thereof
PFIZER11 citations93
US10851081B2Dec 1, 2020
GLP-1 receptor agonists and uses thereof
PFIZER12 citations93
US10669259B2Jun 2, 2020
GLP-1 receptor agonists and uses thereof
PFIZER13 citations93
US7291618B2Nov 6, 2007
Therapeutic compounds
PFIZER23 citations92
US7067515B2Jun 27, 2006
Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
PFIZER24 citations91
US6849620B2Feb 1, 2005
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
PFIZER48 citations91
US10934279B2Mar 2, 2021
GLP-1 receptor agonists and uses thereof
PFIZER9 citations85
US6951868B2Oct 4, 2005
Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
PFIZER14 citations84
US10683281B2Jun 16, 2020
GLP-1 receptor agonists and uses thereof
PFIZER8 citations83
US10676465B2Jun 9, 2020
GLP-1 receptor agonists and uses thereof
PFIZER8 citations83
US12378230B2Aug 5, 2025
GLP-1 receptor agonists and uses thereof
PFIZER1 citations74
US7176198B2Feb 13, 2007
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
PFIZER9 citations73
US11858916B2Jan 2, 2024
GLP-1 receptor agonists and uses thereof
PFIZER2 citations71
US9227956B2Jan 5, 2016
Substituted amide compounds
PFIZER4 citations64
US12319669B2Jun 3, 2025
GLP-1 receptor agonists and uses thereof
PFIZER0 citations62
US11802121B2Oct 31, 2023
GLP-1 receptor agonists and uses thereof
PFIZER0 citations62
US6858613B2Feb 22, 2005
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
PFIZER5 citations62
US6852716B2Feb 8, 2005
Substituted-aryl compounds for treatment of disease
PFIZER6 citations62
US12331041B2Jun 17, 2025
GLP-1 receptor agonists and uses thereof
PFIZER0 citations61
US7465732B2Dec 16, 2008
(2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives
PFIZER0 citations52
US6869946B2Mar 22, 2005
Substituted azabicyclic moieties for the treatment of disease
PFIZER0 citations52
US7485641B2Feb 3, 2009
Substituted 3-amino-pyrrolidino-4-lactams
PFIZER0 citations39
UPJOHN CO
9 patentsUS6500840B2Dec 31, 2002
Quinuclidine-substituted heteroaryl moieties for treatment of disease
UPJOHN CO66 citations95
US6492385B2Dec 10, 2002
Quinuclidine-substituted heteroaryl moieties for treatment of disease
UPJOHN CO70 citations95
US6828330B2Dec 7, 2004
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
UPJOHN CO44 citations92
US6599916B2Jul 29, 2003
Quinuclidine-substituted heteroaryl moieties for treatment of disease
UPJOHN CO53 citations92
US6562816B2May 13, 2003
Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
UPJOHN CO26 citations92
US6486172B2Nov 26, 2002
Quinuclidine-substituted aryl compounds for treatment of disease
UPJOHN CO24 citations92
US6479510B2Nov 12, 2002
Quinuclidine-substituted aryl compounds for treatment of disease
UPJOHN CO41 citations92
US6894042B2May 17, 2005
Azabicyclic compounds for the treatment of disease
UPJOHN CO12 citations84
US6492386B2Dec 10, 2002
Quinuclidine-substituted aryl compounds for treatment of disease
UPJOHN CO19 citations84